礼来公司举办失败研讨会来专门研究那些未研发成功的药物。
Eli Lilly and Company had failure parties to study the drugs that don't work.
再普乐是礼来公司的最畅销的药物。
礼来公司表示，打算对此裁决进行上诉。
目前礼来公司在欧洲已获准以每日一粒的用法进行销售。
It's already approved in Europe where Lilly is launching it now.
礼来公司的一份备案录文档上说，我们将不主动提及糖尿病问题。
"We will NOT proactively address the diabetes concerns, " the document, an internal Lilly memorandum, said.
但是FDA还是会允许礼来公司将欣百达作为止痛药在市场上销售。
However, it would allow Lilly to market Cymbalta as a pain treatment.
他的目标是在礼来公司和全球性试验研究者中间培养开放性的合作。
The goal is to foster open collaboration between Lilly and global laboratory researchers.
辉瑞公司和礼来公司宣布将公布高于（包括）500美元每年的支付。
Pfizer and Lilly said they would report payments of $500 a year or more.
礼来公司正在向FDA申请将欣百达适应症扩展到慢性疼痛，例如因关节炎导致的膝盖疼痛和腰疼。
Lilly is seeking FDA approval for Cymbalta as a treatment for chronic pain conditions such as knee pain caused by osteoarthritis and lower back pain.
夫妻俩同是北京大学的毕业生，1995年到美国攻读硕士学位，现在同一单位——美国礼来公司任职。
The two Peking University graduates moved to the United States to pursue a master's degree in 1995.
总部位于美国印第安纳州印第安纳波利斯的礼来公司通过药品和信息，解决世界上一些最迫切的医疗需求。
Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.
直到2007年礼来公司才在再普乐的标签中增加了反映药物有导致体重明显增加和血糖改变的趋势的严重警告。
Lilly waited until 2007 to add strong warnings to Zyprexa's label to reflect the drug's tendency to cause severe weight gain and blood sugar changes.
奥巴马已签署成为法律专业工作者，如礼来公司莱德贝特酬法和公平的医疗保健扩展到有需要的数百万儿童的立法。
Obama has already signed into law pro-worker legislation like the Lilly Ledbetter Fair Pay Act and an expansion of health care to millions of children in need.
今年，礼来公司进入临床试验的药物一半是生物技术药物。公司计划自2011年起，每年有一个生物技术药物上市。
The company said half of its new drugs entering trials this year will be biologics and it plans to bring a new biotech product to market every year starting in 2011.
2002年，礼来的再普乐在日本上市仅10个月后，该国的卫生官员就要求礼来公司警告医师不要对糖尿病人开再普乐。
And in 2002, only 10 months after Lilly began selling Zyprexa in Japan, medical regulators in that country required Lilly to warn doctors against using Zyprexa in diabetic patients.
在马拉西亚，利用嘉吉食品有限公司油料加工产业中的植物油副产品，礼来公司正与嘉吉公司设立合营企业，开发该植物油。
Elanco is working with Cargill Nutrition Ltd in a joint development venture with this product, utilizing this by-product from Cargill's oil processing business in Malaysia.
该制药商并没有改变其全年盈利预期到2010年，但礼来公司表示，预计收入的增长率为较低的中等水平个位数，低于此前预期。
The drugmaker did not change its full-year 2010 earnings outlook, but said it now expects revenue growth in the low - to mid-single digits, down from a previous estimate for mid-single digit growth.
恰恰相反，根据证人john Gueriguian博士的证词，礼来公司出于药品销售的保护而对医生隐瞒了再普乐的风险。
Instead, Lilly hid Zyprexa's risks from doctors to protect the drug's sales, according to the witness, Dr. John Gueriguian.
在一次采访中，tyrer博士表示，没有理由相信任何其他抗精神病药例如礼来公司奥氮平或阿斯利康公司的思瑞康等用于治疗躁狂将更为有效。
In an interview, Dr. Tyrer said there was no reason to believe that any other antipsychotic drug used for aggression, like Zyprexa from Eli Lilly or Seroquel from AstraZeneca, would be more effective.
FDA在分别对礼来公司和Amylin公司的通报中指出，2009年6月在华盛顿举行的一次医学会议上，其公司代表夸大了百泌达有助于患者减轻体重的作用。
The FDA wrote in a separate letter to Lilly and Amylin that, at a medical meeting in Washington in June 2009, company representatives had overstated the ability of Byetta to help patients lose weight.
直觉会计软件和美国礼来制药两家公司都会定期举行 “失败聚会”。
Intuit, in software, and Eli Lilly, in pharmaceuticals, have both taken to holding “failure parties”.
礼来y公司的临床试验证明，有三分之二的病人在服用欣百达三个月后，腰疼得到缓解。
Two out of three studies Lilly conducted in patients with lower back pain showed the product improved pain relief over about a three-month period.
直觉会计软件和美国礼来制药两家公司都会定期举行“失败聚会”。
Intuit, in software, and Eli Lilly, in pharmaceuticals, have both taken to holding "failure parties".
礼来没有说它的发现具体是什么，但该公司宣布，将结束所有关于类风湿性关节炎治疗药物的临床试验。
Lilly did not say specifically what it found, but it announced that it was ending all trials of the drug for RA.
礼来没有说它的发现具体是什么，但该公司宣布，将结束所有关于类风湿性关节炎治疗药物的临床试验。
Lilly did not say specifically what it found, but it announced that it was ending all trials of the drug for RA.
应用推荐